Stock Rich List
#1601 on the rich list of 14,644 insiders

Justin B. Klee

Co-Chief Executive Officer at Amylyx Pharmaceuticals. Based in Cambridge, Massachusetts.

$92.0M
in disclosed stock, −$1.5M (−1.58%) today
Market closed. Prices as of Nov 19, 4:04 PM ET
Rank
1601st of 14,644
Companies held
1
Largest holding
AMLX, 100.0% of total
Latest SEC filing
Nov 9, 2026

What the $92.0M is made of

Holdings counted

All filings on SEC.gov
CompanyHow heldSharesPriceValueShare of totalReported
Amylyx Pharmaceuticals AMLX
Common Stock
Directly3,513,056$26.20$92.0M100.0%Form 4, Nov 9, 2026

Share counts are the amounts Justin B. Klee reported owning after each line of their latest filing for that company, adjusted for any later stock splits. Values use the latest price. Methodology.

Open-market trades, last 12 months

DateTradeCompanySharesPriceValueFiling
Nov 9, 2026SoldAMLX37,483$29.39$1.1MView
Nov 9, 2026SoldAMLX62,517$30.11$1.9MView
Sep 10, 2026SoldAMLX1,439$33.16$48KView
Sep 10, 2026SoldAMLX29,025$32.13$933KView
Mar 2, 2026SoldAMLX29,282$14.47$424KView
Feb 2, 2026SoldAMLX15,500$14.69$228KView
Jan 16, 2026SoldAMLX1,995$13.89$28KView
Jan 15, 2026SoldAMLX136,193$13.58$1.8MView
Jan 6, 2026SoldAMLX7,715$11.09$86KView

Nearby on the list

Full list
Nearby ranks
RankNameStock holdingsToday
1598J. Duncan Smith
Vice President/Secretary, Sinclair. Cockeysville, MD
$92.2M−$1.3M (−1.41%)
1599Zhitao He
Director, Newegg Commerce. Diamond Bar, CA
$92.1M+$5.3M (+6.15%)
1600Joshua B. Cohen
Co-Chief Executive Officer, Amylyx Pharmaceuticals. Cambridge, MA
$92.0M−$1.5M (−1.58%)
1601Justin B. Klee
Co-Chief Executive Officer, Amylyx Pharmaceuticals. Cambridge, MA
$92.0M−$1.5M (−1.58%)
1602Daniel O'Day
Chairman & CEO, Gilead Sciences. Foster City, CA
$91.9M−$1.4M (−1.45%)
1603Rehan Jaffer
Director, Six Flags Entertainment. New York, NY
$91.8M+$541K (+0.59%)
1604Joseph P. Adams Jr.
CEO and Chairman, FTAI Aviation. New York, NY
$91.8M−$2.2M (−2.35%)

Other Amylyx Pharmaceuticals insiders

All AMLX insiders

Questions

How much stock does Justin B. Klee own?

Justin B. Klee holds $92,042,067 in listed stock based on SEC filings and current prices, mostly Amylyx Pharmaceuticals (AMLX). That ranks 1601st on the Stock Rich List.

Is this Justin B. Klee's net worth?

No. It counts only listed shares reported on SEC Forms 3, 4 and 5. Cash, private companies, real estate, options and holdings that don't need to be reported are not included, so total net worth is likely different.

When did Justin B. Klee last buy or sell stock?

The most recent open-market trade on file is a sale of 37,483 AMLX shares on Nov 9, 2026 at $29.39.